Guardant Health Officer Files to Sell $866K in Stock
Guardant Health, Inc.
Subscribe to track GH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Guardant Health Officer Files to Sell $866K in Stock
Company: Guardant Health, Inc. (GH) Form: 144 | Filed: 2025-11-07 Significance: Low
Insider: Saia John G. Title: Officer | Relationship: Officer
Transaction: • Type: Proposed Sale • Shares: 8,996 • Price: ~$96.25 • Value: $865,865 • Owned After: Not Disclosed
Key Insight: An officer filed a notice of a proposed sale of shares valued at approximately $866K. The transaction size is negligible compared to the company's market capitalization.
Market Context: This sale represents 0.007% of shares outstanding and 0.007% of the company's $12.47B market cap, indicating it is likely a routine financial management activity by the insider.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Guardant Health, Inc. (GH)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer of Guardant Health has filed a notice of intent to sell shares worth approximately $866,000.
- Market Impact: The transaction is considered immaterial and is unlikely to have any impact on the stock price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | Guardant Health, Inc. |
| Ticker Symbol | GH |
| CIK | 0001576280 |
| Industry | Medical Laboratories |
Insider Information
| Field | Value |
|---|---|
| Name | Saia John G. |
| CIK | 0001737840 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-07 (Approximate Sale Date) |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 8,996 |
| Price Per Share | ~$96.25 (implied) |
| Total Value | $865,865 |
| Shares Owned After | Not Disclosed |
| Ownership Type | Not Disclosed |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $865,865 |
| % of Market Cap | 0.007% |
| Shares Transacted | 8,996 |
| % of Shares Outstanding | 0.007% |
| Post-Transaction Ownership | Not Disclosed |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The proposed sale of $865,865 is a very small fraction of Guardant Health's $12.47 billion market capitalization.
- Transaction Significance: The sale is classified as low significance as it falls far below the materiality thresholds of 0.1% of market cap and 0.1% of shares outstanding.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: A transaction of this size is routine and does not signal any significant change in the insider's outlook on the company. It is likely for personal financial planning.
Volume & Sentiment
- Expected Volume Impact: None. The number of shares is too small to affect trading volume.
- Sentiment Indicator: Neutral. The market is unlikely to react to this filing.
Additional Context
Transaction Notes
- Source of Shares: The shares were originally acquired as part of an equity compensation plan (RSU/PSU) between April 2021 and September 2023.
- Filing Type: Form 144 is a notice of a proposed sale, not a confirmation that the sale has been executed. The sale is intended to occur on or around November 7, 2025.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.